{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260531541836/en/Izalontamab-Brengitecan-Iza-Bren-Demonstrates-Statistically-Significant-and-Clinically-Meaningful-Improvements-in-Overall-Survival-and-Progression-Free-Survival-in-Patients-with-Triple-Negative-Breast-Cancer-and-Esophageal-Squamous-Cell-Carcinoma", "message": "News view counter 773209 successfully enlarged"}